Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Salivary Gland Neoplasms × Aspirin × Clear all

Sponsor

Conditions

Colorectal Neoplasms 4 Multiple Myeloma 3 Barrett Esophagus 3 Venous Thromboembolism 2 Precancerous Conditions 2 Myocardial Infarction 2 Esophageal Neoplasms 2 Colonic Neoplasms 2 Breast Neoplasms 2 Vascular Diseases 1 Triple Negative Breast Neoplasms 1 Tobacco Use Disorder 1 Thromboembolism 1 Thrombocytopenia 1 Stroke 1 Soft Tissue Neoplasms 1 Smoking Cessation 1 Sarcoma 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Polycythemia Vera 1 Ovarian Neoplasms 1 Node Positive HER2 Negative Breast Cancer 1 Neoplasms, Plasma Cell 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Myocardial Ischemia 1 Myeloproliferative Disorders 1 Multiple Pulmonary Nodules 1 Melanoma 1

Interventions

Cetuximab 3 Vorinostat 2 Radiosurgery 2 Nivolumab 2 Ipilimumab 2 Dasatinib 2 Cisplatin 2 Bevacizumab 2 temsirolimus 1 pembrolizumab 1 ispinesib 1 eribulin 1 dehydroftorafur 1 apalutamide 1 alectinib 1 Sorafenib 1 Sirolimus 1 Platinum 1 Pilocarpine 1 Oral Hygiene 1 N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 1 Moxibustion 1 Magnetic Resonance Spectroscopy 1 MK 2206 1 Lapatinib 1 Irinotecan 1 Immunoglobulin G 1 Gonadotropin-Releasing Hormone 1 Gemcitabine 1 Gefitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡